Pharmaceuticals, Biotechnology and Life Sciences
The International Liver Cancer Association (ILCA) Annual Conference has selected the Can-Fite abstract for presentation Phase III trial for Namodenoson…
The International Liver Cancer Association (ILCA) Annual Conference has selected the Can-Fite abstract for presentation Phase III trial for Namodenoson…
STAMFORD, Conn.–(BUSINESS WIRE)–SpringWorks Therapeutics, a clinical-stage biopharmaceutical company focused on developing life-changing medicines for patients with severe rare diseases and…
CAMBRIDGE, England–(BUSINESS WIRE)–Owlstone Medical, the global leader in Breath Biopsy® for applications in early disease detection and precision medicine today…
Daniele Piomelli, Ph.D., Ryan Vandrey, Ph.D. and David Casarett, MD, MA Join distinguished group of Scientific Advisors TORONTO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/FSDDF?src=hash"…
Exploratory data showed a greater proportion of patients receiving vedolizumab achieved clinical response at week 14 than adalimumab Additional exploratory…
Investigational candidate developed by Gelesis demonstrated significant 16 hour reduction in colonic transit time in patients with chronic idiopathic constipation…
New funding to support platform advancements and proprietary pipeline expansion NEW YORK–(BUSINESS WIRE)–Schrödinger today announced that several new investors have…
Interim results from ongoing ORION-3 study demonstrated sustained lowering of LDL-C by more than 50 percent, with time-averaged absolute reductions…
NEW ORLEANS–(BUSINESS WIRE)–lt;a href="https://twitter.com/search?q=%24AMRX&src=ctag" target="_blank"gt;$AMRXlt;/agt; lt;a href="https://twitter.com/hashtag/AMRX?src=hash" target="_blank"gt;#AMRXlt;/agt;–Former Attorney General of Louisiana, Charles C. Foti, Jr., Esq., a partner at…